Neuropharmacology and Stereochemistry of Dopamine Receptor Agonist and Antagonist Enantiomeric Pairs

References

• Seeman P. Brain dopamine receptors. Pharmacol. Rev. 1980; 32: 229–313
   PubMed Web of Science ®Google Scholar
• Humber L. G., Bruderlein F. T., Voith K. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. A hypothesis on their mode of interaction with the central dopamine receptor. Mol. Pharmacol. 1975; 11: 833–840
   Google Scholar
• Saari W. S., King S. W., Lotti V. J. Synthesis and biological activity of (6aS)-10,11-dihydroxyaporphine, the optical antipode of apomorphine. J. Med. Chem. 1973; 16: 171–172
   Google Scholar
• Neumeyer J. L. The Chemistry and Biology of Isoquinoline Alkaloids, J. D. Phillipson, M. F. Roberts, M. H. Zenk. Springer-Verlag, Berlin 1985; 146–170
   Google Scholar
• Riffee W. H., Wilcox R. E., Smith R. V., Davis P. J., Brubaker A. Advances in the Biosciences, Vol. 37, Advances in Dopamine Research, M. Kohsaka, T. Shohmori, T. Tsokada, G. N. Woodruff. Pergamon Press, London 1982; 357–362
   Google Scholar
• Neumeyer J. L., Law S. J., Lamont J. S. Apomorphine and Other Dopaminomimetics, Vol. 1. Basic Pharmacology, G. L. Gessa, G. U. Corsini. Raven Press, New York 1981; 209–219
   Google Scholar
• Neumeyer J. L., Arana G. W., Ram V. J., Baldessarini R. J. Synthesis and structure-activity relationships of aporphines at central dopamine receptors. Acta Pharm. Suec. 1983, Suppl. 2: 11–24
   Google Scholar
• Arana G. W., Baldessarini R. J., Neumeyer J. L. Structure-activity relationships of aporphines at central dopamine receptors. Acta Pharm. Suec. 1983, Suppl. 2: 25–36
   Google Scholar
• Neumeyer J. L., Reischig D., Arana G. W., Campbell A., Baldessarini R. J., Kula N. S., Watling K. J. Aporphines. 48. Enantioselectivity of (R)-(-) and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors. J. Med. Chem. 1983; 26: 516–521
   Google Scholar
• Granchelli F. E., Neumeyer J. L. Synthesis of hydroxyaporphines and a study of their possible dopamine receptor stimulating properties. Pharmacologist 1971; 13: 252
   Google Scholar
• Neumeyer J. L., Granchelli F. E., Fuxe K., Ungerstedt U., Corrodi H. Aporphines II. Synthesis and Dopaminergic activity of monohydroxyaporphines. Total synthesis of (±)11-hydroxyaporphine, (±)11-hydroxy-N-n-propylnoraporphine. J. Med. Chem. 1974; 17: 1090–1095
   Google Scholar
• Schoenfeld R. J., Neumeyer J. L., Dafeldecker W., Roffler-Tarlov S. Comparison of structural and stereoisomers of apomorphine on stereotyped sniffing behavior of the rat. Eur. J. Pharmacol. 1975; 30: 63–68
   Google Scholar
• Hjorth S., Carlsson A., Wikstrom H., Lindberg P., Sanchez D., Hacksell U., Arvidsson L. E., Svensson U., Nilsson J. L.G. 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. Life Sci. 1981; 28: 1225–1238
   Google Scholar
• Johansson A. M., Arvidsson L.-E., Hacksell U., Nilsson J. L.G., Svensson K., Hjorth S., Clark D., Carlsson A., Sanchez D., Andersson B., Wikstrom H. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors. J. Med. Chem. 1985; 28: 1049–1053
   Google Scholar
• Campbell A., Baldessarini R. J., Teicher M. H., Neumeyer J. L. S(+)Apomorphines. Selective inhibition of excitatory effects of dopamine injected into the limbic system of the rat. Neuropharmacology 1985; 24: 391–399
   PubMed Web of Science ®Google Scholar
• Campbell A., Baldessarini R. J., Teicher M. H., Neumeyer J. L. Behavioral effects of apomorphine isomers in the rat: Selective locomotor-inhibitory effects of S(+)N-n-propylnor-apomorphine. Psychopharmacology 1986; 88: 158–164
   Google Scholar
• Arana G. W., Baldessarini R. J., Lamont J. S., Amlicke D., Neumeyer J. L. Pharmacology of high-affinity binding of [3H](+)2-amino-6,7-dihydroxyl-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissues. Biochem. Pharmacol. 1983; 32: 2873–2880
   Google Scholar
• Kula N. S., Baldessarini R. J., Bromley S., Neumeyer J. L. Effects of isomers of apomorphines on dopamine receptors in striatal and limbic tissue of rat brain. Life Sci. 1985; 37: 1051–1057
   Google Scholar
• Campbell A., Baldessarini R. J., Stoll A., Teicher M. H., Maynard P. Effect of age on behavioral responses and tissue levels of apomorphine in the rat. Neuropharmacology 1984; 23: 725–730
   Google Scholar
• Froimowitz M., Neumeyer J. L., Baldessarini R. J. A stereochemical explanation of the dopamine agonist and antagonist activity of stereoisomeric pairs. J. Med. Chem. 1986; 29: 1570–1573
   Google Scholar
• Hacksell U., Arvidsson L.-E., Svensson U., Nilsson J. L.G., Sanchez D., Wikstrom H., Lindberg P., Hjorth S., Carlsson A. 3-Phenylpiperidines. Central dopamine-autoreceptors stimulating activity. J. Med. Chem. 1981; 24: 1475–1482
   PubMed Web of Science ®Google Scholar
• Seeman P., Watanabe M., Grigoriadis D., Tedesco J. L., George S. R., Svensson U., Nilsson J. L.G., Neumeyer J. L. Dopamine D2 receptor binding sites for agonists. A tetrahedral model. Mol. Pharmacol. 1985; 28: 391–399
   PubMedGoogle Scholar
• Wikstrom H., Andersson B., Sanchez D., Lindberg P., Arvidsson L.-E., Johansson A. M., Nilsson J. L.G., Svensson K., Hjorth S., Carlsson A. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octohydrobenzo[f]-quinolines: Structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists. J. Med. Chem. 1985; 28: 215–225
   Google Scholar